Novel Findings for the Development of Drug Therapy for Various Liver Diseases: Genetic Variation in IL-28B Is Associated With Response to the Therapy for Chronic Hepatitis C
Hepatitis C infection is a global health problem. Spontaneous viral clearance was observed in approximately 30% of individuals with acute infection. In the therapy using a combination of pegylated interferon-α and ribavirin, approximately 50% of chronic hepatitis C patients infected with high viremi...
Main Authors: | Masaya Sugiyama, Yasuhito Tanaka, Makoto Nakanishi, Masashi Mizokami |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-01-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861319307546 |
Similar Items
-
Genetic variation of the IL-28B promoter affecting gene expression.
by: Masaya Sugiyama, et al.
Published: (2011-01-01) -
IL28B polymorphisms and clinical implications for hepatitis C virus infection in Uzbekistan.
by: Dinara Khudayberganova, et al.
Published: (2014-01-01) -
Prediction of Drug Therapy for Chronic Hepatitis C Depending on the IL28B Gene Polymorphism
by: Moroz L.V. Moroz L.V., et al.
Published: (2014-09-01) -
Influence of hepatitis C virus and IL28B genotypes on liver stiffness.
by: Lene Fogt Lundbo, et al.
Published: (2014-01-01) -
Genome-wide copy number variation analysis of hepatitis B infection in a Japanese population
by: Masataka Kikuchi, et al.
Published: (2021-06-01)